In an SEC filing, Neuros Medical Inc. of Willoughby Hills said it has raised $37 million of a planned $42.8 million stock offering.
The company, which is developing a patented therapy for the treatment of chronic, post-amputation pain with a high frequency electrical signal, said in the filing that it is not being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer. It offered no other explanation for the offering.
Click here to read the complete story.
Story excerpt provided by Crain’s Cleveland Business.
Written by Jay Miller.
Originally published November 11, 2020.